Prognostic Impact of <i>EGFR</i> Amplification and Visceral Pleural Invasion in Early Stage Pulmonary Squamous Cell Carcinomas Patients after Surgical Resection of Primary Tumor
Over the last few decades, an increasing amount of information has been accumulated on biomarkers in non-small cell lung cancer (NSCLC). Despite these advances, most biomarkers have been identified in the adenocarcinoma histological subtype (AC). However, the application of molecular-targeted therap...
Main Authors: | Luís Miguel Chinchilla-Tábora, José María Sayagués, Idalia González-Morais, Marta Rodríguez, María Dolores Ludeña |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-04-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/14/9/2174 |
Similar Items
-
Real-World Data on Combined EGFR-TKI and Crizotinib Treatment for Acquired and De Novo <i>MET</i> Amplification in Patients with Metastatic <i>EGFR</i>-Mutated NSCLC
by: Edyta M. Urbanska, et al.
Published: (2023-08-01) -
Amplification of the <i>EGFR</i> and <i>CCND1</i> Are Coordinated and Play Important Roles in the Progression of Oral Squamous Cell Carcinomas
by: Huei-Tzu Chien, et al.
Published: (2019-05-01) -
Case report: EGFR fusion mutation combined with EGFR amplification responds to EGFR-TKI therapy
by: Zhulin Wang, et al.
Published: (2024-03-01) -
Cigarette Smoke Containing Acrolein Upregulates EGFR Signaling Contributing to Oral Tumorigenesis In Vitro and In Vivo
by: Han-Hsing Tsou, et al.
Published: (2021-07-01) -
Effect of EGFR amplification on the prognosis of EGFR-mutated advanced non–small-cell lung cancer patients: a prospective observational study
by: Duanyang Peng, et al.
Published: (2022-12-01)